Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which ...

Scientists have found a way to fine-tune a central fat-control pathway in the liver, reducing harmful blood triglycerides ...

Understand why testing must evolve beyond deterministic checks to assess fairness, accountability, resilience and ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

For more than a century, dentistry has focused on repairing or replacing damaged teeth, not growing new ones. That assumption is now under direct challenge, as Japanese teams move a first-of-its-kind ...

In this week's "It's Debatable" segment, Rick Rosen and Charles Moster debate on the question: Should ethical/legal restrictions on human testing be lifted to expedite the development of new ...